-
SBI Healthcare Opportunities Fund Regular Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 06/12/23 )
NAV
₹185.48
Last change
₹-1.3 -0.01%
Fund Size (AUM)
1982.47 Cr
Performance
20.17% (5Y)
Fund Details
SBI Healthcare Opportunities Fund Regular Reinvestment Inc Dist cum Cap Wdrl
as of 06/12/23
AUM
1982.47 Cr
Expense Ratio
2.1 %
Benchmark
S&P BSE Healthcare TR INR
ISIN
INF200K01461
Fund Manager
Tanmaya Desai
Exit Load
0.5% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities Fund Regular Reinvestment Inc Dist cum Cap Wdrl | 28.95% | 15.72% | 20.17% |
| S&P BSE Healthcare TR INR | 26.85% | 14.34% | 16.21% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.18% |
Cipla Ltd |
8.17% |
Divi's Laboratories Ltd |
6.84% |
Aether Industries Ltd |
6.22% |
Max Healthcare Institute Ltd Ordinary Shares |
5.21% |
Mankind Pharma Ltd |
4.92% |
Global Health Ltd |
4.75% |
Krishna Institute of Medical Sciences Ltd |
4.57% |
Jupiter Life Line Hospitals Ltd |
4.46% |
Rainbow Childrens Medicare Ltd |
4.29% |
Sector Allocation
Healthcare |
92.15% |
Basic Materials |
7.85% |
Asset Allocation
-
97%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
Nippon India Pharma IDCW-P
Equity healthcare-
Returns
-
22.91% (5Y)
-
-
Nippon India Pharma IDCW-R
Equity healthcare-
Returns
-
22.91% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
20.17% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
20.17% (5Y)
-
-
Nippon India Pharma Gr
Equity healthcare-
Returns
-
20.51% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
23.3% (5Y)
-
